Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C15H13O4.Na |
| Molecular Weight | 280.2511 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].COC1=C2C=CC=CC2=C(C=C1)C(=O)CCC([O-])=O
InChI
InChIKey=SJGXLANXNYFCEV-UHFFFAOYSA-M
InChI=1S/C15H14O4.Na/c1-19-14-8-6-11(13(16)7-9-15(17)18)10-4-2-3-5-12(10)14;/h2-6,8H,7,9H2,1H3,(H,17,18);/q;+1/p-1
| Molecular Formula | C15H13O4 |
| Molecular Weight | 257.2613 |
| Charge | -1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | Na |
| Molecular Weight | 22.98976928 |
| Charge | 1 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Menbutone is a choleretic compound which is used in veterinary medicine at a dose rate up to 10 mg/kg bw by parenteral (intravenous or intramuscular) route in bovine, ovine, caprine, porcine, and equine species. Menbutone stimulates the digestive tract by increasing excretion of bile, gastric acid, and pancreatic juices by two to five times baseline. It is marketed for veterinary use in Europe under several brand names.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Genabil Approved UseMenbutone is only to be administered to a small number of animals or individual animals which are not intended for immediate slaughter. The total daily intake should be at most 3.6 mg per person of 60 kg bw per day, resulting from the ADI of 0.06 mg/kg bw/day. Launch Date1996 |
Overview
| CYP3A4 | CYP2C9 | CYP2D6 | hERG |
|---|---|---|---|
OverviewOther
| Other Inhibitor | Other Substrate | Other Inducer |
|---|---|---|
Drug as perpetrator​
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no | ||||
| no |
Drug as victim
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| no |
Tox targets
| Target | Modality | Activity | Metabolite | Clinical evidence |
|---|---|---|---|---|
| Substance Class |
Chemical
Created
by
admin
on
Edited
Tue Apr 01 19:31:36 GMT 2025
by
admin
on
Tue Apr 01 19:31:36 GMT 2025
|
| Record UNII |
V0R5844J2S
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
111961-03-6
Created by
admin on Tue Apr 01 19:31:36 GMT 2025 , Edited by admin on Tue Apr 01 19:31:36 GMT 2025
|
PRIMARY | |||
|
V0R5844J2S
Created by
admin on Tue Apr 01 19:31:36 GMT 2025 , Edited by admin on Tue Apr 01 19:31:36 GMT 2025
|
PRIMARY | |||
|
23679714
Created by
admin on Tue Apr 01 19:31:36 GMT 2025 , Edited by admin on Tue Apr 01 19:31:36 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |